Combination treatment with pioglitazone and fenofibrate attenuates pioglitazone-mediated acceleration of bone loss in ovariectomized rats
Peroxisome proliferator-activated receptor (PPAR) γ agonists, such as pioglitazone (Pio), improve glycemia and lipid profile but are associated with bone loss and fracture risk. Data regarding bone effects of PPARα agonists (including fenofibrate (Feno)) are limited, although animal studies suggest...
Saved in:
Published in | Journal of endocrinology Vol. 212; no. 2; pp. 179 - 186 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Bristol
BioScientifica
01.02.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Peroxisome proliferator-activated receptor (PPAR) γ agonists, such as pioglitazone (Pio), improve glycemia and lipid profile but are associated with bone loss and fracture risk. Data regarding bone effects of PPARα agonists (including fenofibrate (Feno)) are limited, although animal studies suggest that Feno may increase bone mass. This study investigated the effects of a 13-week oral combination treatment with Pio (10 mg/kg per day)+Feno (25 mg/kg per day) on body composition and bone mass parameters compared with Pio or Feno alone in adult ovariectomized (OVX) rats, with a 4-week bone depletion period, followed by a 6-week treatment-free period. Treatment of OVX rats with Pio+Feno resulted in ∼50% lower fat mass gain compared with Pio treatment alone. Combination treatment with Pio+Feno partially prevented Pio-induced loss of bone mineral content (∼45%) and bone mineral density (BMD; ∼60%) at the lumbar spine. Similar effects of treatments were observed at the femur, most notably at sites rich in trabecular bone. At the proximal tibial metaphysis, concomitant treatment with Pio+Feno prevented Pio exacerbation of ovariectomy-induced loss of trabecular bone, resulting in BMD values in the Pio+Feno group comparable to OVX controls. Discontinuation of Pio or Feno treatment of OVX rats was associated with partial reversal of effects on bone loss or bone mass gain, respectively, while values in the Pio+Feno group remained comparable to OVX controls. These data suggest that concurrent/dual agonism of PPARγ and PPARα may reduce the negative effects of PPARγ agonism on bone mass. |
---|---|
AbstractList | Peroxisome proliferator-activated receptor (PPAR) gamma agonists, such as pioglitazone (Pio), improve glycemia and lipid profile but are associated with bone loss and fracture risk. Data regarding bone effects of PPAR alpha agonists (including fenofibrate (Feno)) are limited, although animal studies suggest that Feno may increase bone mass. This study investigated the effects of a 13-week oral combination treatment with Pio (10 mg/kg per day)+Feno (25 mg/kg per day) on body composition and bone mass parameters compared with Pio or Feno alone in adult ovariectomized (OVX) rats, with a 4-week bone depletion period, followed by a 6-week treatment-free period. Treatment of OVX rats with Pio+Feno resulted in similar to 50% lower fat mass gain compared with Pio treatment alone. Combination treatment with Pio+Feno partially prevented Pio-induced loss of bone mineral content ( similar to 45%) and bone mineral density (BMD; similar to 60%) at the lumbar spine. Similar effects of treatments were observed at the femur, most notably at sites rich in trabecular bone. At the proximal tibial metaphysis, concomitant treatment with Pio+Feno prevented Pio exacerbation of ovariectomy-induced loss of trabecular bone, resulting in BMD values in the Pio+Feno group comparable to OVX controls. Discontinuation of Pio or Feno treatment of OVX rats was associated with partial reversal of effects on bone loss or bone mass gain, respectively, while values in the Pio+Feno group remained comparable to OVX controls. These data suggest that concurrent/dual agonism of PPAR gamma and PPAR alpha may reduce the negative effects of PPAR gamma agonism on bone mass. Peroxisome proliferator-activated receptor (PPAR) γ agonists, such as pioglitazone (Pio), improve glycemia and lipid profile but are associated with bone loss and fracture risk. Data regarding bone effects of PPARα agonists (including fenofibrate (Feno)) are limited, although animal studies suggest that Feno may increase bone mass. This study investigated the effects of a 13-week oral combination treatment with Pio (10 mg/kg per day)+Feno (25 mg/kg per day) on body composition and bone mass parameters compared with Pio or Feno alone in adult ovariectomized (OVX) rats, with a 4-week bone depletion period, followed by a 6-week treatment-free period. Treatment of OVX rats with Pio+Feno resulted in ∼50% lower fat mass gain compared with Pio treatment alone. Combination treatment with Pio+Feno partially prevented Pio-induced loss of bone mineral content (∼45%) and bone mineral density (BMD; ∼60%) at the lumbar spine. Similar effects of treatments were observed at the femur, most notably at sites rich in trabecular bone. At the proximal tibial metaphysis, concomitant treatment with Pio+Feno prevented Pio exacerbation of ovariectomy-induced loss of trabecular bone, resulting in BMD values in the Pio+Feno group comparable to OVX controls. Discontinuation of Pio or Feno treatment of OVX rats was associated with partial reversal of effects on bone loss or bone mass gain, respectively, while values in the Pio+Feno group remained comparable to OVX controls. These data suggest that concurrent/dual agonism of PPARγ and PPARα may reduce the negative effects of PPARγ agonism on bone mass. |
Author | Bénardeau, Agnes Samadfam, Rana Sebokova, Elena Bauss, Frieder Awori, Malaika Smith, Susan Y Wright, Matthew |
Author_xml | – sequence: 1 givenname: Rana surname: Samadfam fullname: Samadfam, Rana – sequence: 2 givenname: Malaika surname: Awori fullname: Awori, Malaika – sequence: 3 givenname: Agnes surname: Bénardeau fullname: Bénardeau, Agnes – sequence: 4 givenname: Frieder surname: Bauss fullname: Bauss, Frieder – sequence: 5 givenname: Elena surname: Sebokova fullname: Sebokova, Elena – sequence: 6 givenname: Matthew surname: Wright fullname: Wright, Matthew – sequence: 7 givenname: Susan Y surname: Smith fullname: Smith, Susan Y |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25436300$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22062085$$D View this record in MEDLINE/PubMed |
BookMark | eNp90U2PFCEQBmBi1rizqyfvpi9GE9NaQAPdRzNZv7LJXvTcKWhaMd0wAqNx_4H_2prMqPGyJyjypAp4L9hZTNEz9pjDS64kvPpwc9Vy3oJU-h7b8M4Mre5BnbENgBAtmEGds4tSvgJwxY18wM6FAC2gVxv2a5tWGyLWkGJTs8e6-libH6F-aXYhfV5CxVua12CcmtnHNAebsVJdq4972pX_XLv6KdDp1KBzfvH52DnNjT10WVIpTaD6O-bgXU1ruCVLqjxk92dcin90Wi_ZpzdXH7fv2uubt--3r69b20morXa-m4WTnZJOohXWTNbxXsrOecmhE5M2AiVyaYzUaLp-6K0EroVxvQMuL9mzY99dTt_2vtRxDYWuumD0aV_GgWuuQA1A8vmdkoPo6Xe1GYi-OFKX6YXZz-MuhxXzT0LjIaWRUho5Hw8pkX5yary39F9_7Z9YCDw9ASwOlzljdKH8c6qTWsLhhvzobEjFBUouzMHhncN_A9DOrfw |
CODEN | JOENAK |
CitedBy_id | crossref_primary_10_1002_jbmr_1918 crossref_primary_10_1007_s00774_014_0632_4 crossref_primary_10_1097_CORR_0000000000000713 crossref_primary_10_3389_fendo_2023_1145467 crossref_primary_10_1002_prp2_136 crossref_primary_10_1007_s13340_014_0157_z crossref_primary_10_1002_dmrr_3100 crossref_primary_10_3390_ijms18061282 crossref_primary_10_1016_j_pharep_2017_05_008 crossref_primary_10_1517_14740338_2013_741585 crossref_primary_10_4236_jbnb_2024_151001 |
Cites_doi | 10.1016/S0014-5793(00)01372-7 10.2337/dc05-1146 10.1016/S0140-6736(09)60870-9 10.2337/diabetes.47.4.507 10.1002/jbmr.5650241305 10.1210/jc.2007-2249 10.1172/JCI200419900 10.1007/s00223-004-0224-8 10.3132/dvdr.2007.039 10.1007/s11154-010-9153-1 10.1186/1472-6823-11-11 10.1186/1472-6823-9-10 10.1615/CritRevEukarGeneExpr.v19.i3.10 10.1097/MOL.0b013e32832dd4b1 10.1161/ATVBAHA.108.179689 10.1056/NEJMoa066224 10.1021/jm058056x 10.1210/rp.57.1.385 10.1210/jc.2006-2646 10.1186/1471-213X-8-71 10.2215/CJN.04151206 |
ContentType | Journal Article |
Copyright | 2012 Society for Endocrinology 2015 INIST-CNRS |
Copyright_xml | – notice: 2012 Society for Endocrinology – notice: 2015 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7X8 |
DOI | 10.1530/JOE-11-0356 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | Calcium & Calcified Tissue Abstracts CrossRef MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
DocumentTitleAlternate | Effects of PPARα and γ activation on bone mass |
EISSN | 1479-6805 |
EndPage | 186 |
ExternalDocumentID | 10_1530_JOE_11_0356 22062085 25436300 |
Genre | Research Support, Non-U.S. Gov't Journal Article Comparative Study |
GroupedDBID | - 02 08R 0R 2WC 3O- 4.4 53G 55 5GY 5RE 5VS AAFZV AAYJJ ABFLS ABLYK ABOCM ABPTK ABSGY ABSQV ACNCT ACPRK ADACO ADBBV ADBIT ADDZX AENEX AFDAS AFFNX AGCAB ALMA_UNASSIGNED_HOLDINGS BAWUL CS3 DIK DU5 E3Z EBS EJD F5P FA8 FH7 GJ GX1 H13 HZ H~9 IL9 INIJC J5H K-O KM KQ8 L7B MVM O0- O9- OHT OK1 P2P REN RHF TBS VH1 WH7 WOQ X X7M XJT ZA5 ZGI ZXP --- -~X .55 .GJ 0R~ 18M AAUGY ACGFO AFHIN AFOSN AI. BTFSW F9R HF~ HZ~ IQODW W8F WHG ~02 ~KM CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7X8 |
ID | FETCH-LOGICAL-b430t-6ce4f2c3453c3ab2b7dbc18334ce31042d672a3a137736a74898b301627c8c013 |
ISSN | 0022-0795 |
IngestDate | Sat Aug 17 04:09:02 EDT 2024 Fri Aug 16 11:59:13 EDT 2024 Fri Aug 23 00:29:20 EDT 2024 Sat Sep 28 07:50:26 EDT 2024 Sun Oct 22 16:05:37 EDT 2023 Wed Apr 14 02:20:59 EDT 2021 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Agonist Ovariectomy Rat Fibrate derivatives Pioglitazone Diseases of the osteoarticular system Rodentia Thiazolidinedione derivatives PPAR-γ receptor Fenofibrate Vertebrata Mammalia Treatment Animal Acceleration Osteopenia |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-b430t-6ce4f2c3453c3ab2b7dbc18334ce31042d672a3a137736a74898b301627c8c013 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
OpenAccessLink | http://dx.doi.org/10.1530/JOE-11-0356 |
PMID | 22062085 |
PQID | 1028079679 |
PQPubID | 23462 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_916150590 proquest_miscellaneous_1028079679 crossref_primary_10_1530_JOE_11_0356 pubmed_primary_22062085 pascalfrancis_primary_25436300 bioscientifica_primary_10_1530_JOE_11_0356 |
PublicationCentury | 2000 |
PublicationDate | 2012-02-01 |
PublicationDateYYYYMMDD | 2012-02-01 |
PublicationDate_xml | – month: 02 year: 2012 text: 2012-02-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Bristol |
PublicationPlace_xml | – name: Bristol – name: England |
PublicationTitle | Journal of endocrinology |
PublicationTitleAlternate | J Endocrinol |
PublicationYear | 2012 |
Publisher | BioScientifica |
Publisher_xml | – name: BioScientifica |
References | Karpe (13_35042096) 2009; 20 Boyce (3_35911863) 2009; 19 Sottile (21_18528270) 2004; 75 Spiegelman (22_5981599) 1998; 47 (6_41528663) 2010; 11 (24_41528669) 2009; 9 (7_30484177) 2008; 93 (19_41528667) 2008; 2008 Jackson (11_6550618) 2000; 471 Henry (10_35049595) 2009; 374 (18_41528666) 2006; 2006 (12_23029165) 2006; 355 Sierra (20_23719989) 2007; 50 (23_41528668) 2011; 11 Manolagas (17_17057524) 2002; 57 Akune (1_18124690) 2004; 113 Lalloyer (16_37042585) 2010; 30 (2_41528662) 2007; 4 (8_23578884) 2007; 92 Kendall (14_22012599) 2006; 29 Clarke (5_32284895) 2008; 3 (15_41528665) 2009; 24 (4_35211627) 2007; 40 (9_41528664) 2008; 8 |
References_xml | – volume: 471 start-page: 119 issn: 1873-3468 issue: 1 year: 2000 ident: 11_6550618 publication-title: FEBS Letters doi: 10.1016/S0014-5793(00)01372-7 contributor: fullname: Jackson – volume: 29 start-page: 1016 issn: 0149-5992 issue: 5 year: 2006 ident: 14_22012599 publication-title: Diabetes Care doi: 10.2337/dc05-1146 contributor: fullname: Kendall – volume: 374 start-page: 126 issn: 0140-6736 issue: 9684 year: 2009 ident: 10_35049595 publication-title: Lancet doi: 10.1016/S0140-6736(09)60870-9 contributor: fullname: Henry – volume: 2008 start-page: 297893 year: 2008 ident: 19_41528667 publication-title: PPAR RESEARCH – volume: 47 start-page: 507 issn: 0012-1797 issue: 4 year: 1998 ident: 22_5981599 publication-title: Diabetes doi: 10.2337/diabetes.47.4.507 contributor: fullname: Spiegelman – volume: 24 start-page: S370 issn: 0884-0431 year: 2009 ident: 15_41528665 publication-title: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research doi: 10.1002/jbmr.5650241305 – volume: 93 start-page: 1696 issn: 0021-972X issue: 5 year: 2008 ident: 7_30484177 publication-title: Journal of Clinical Endocrinology & Metabolism doi: 10.1210/jc.2007-2249 – volume: 40 start-page: 149 issn: 1873-2763 year: 2007 ident: 4_35211627 – volume: 113 start-page: 846 issn: 0021-9738 issue: 6 year: 2004 ident: 1_18124690 publication-title: Journal of Clinical Investigation doi: 10.1172/JCI200419900 contributor: fullname: Akune – volume: 2006 start-page: 24502 year: 2006 ident: 18_41528666 publication-title: PPAR RESEARCH – volume: 75 start-page: 329 issn: 1432-0827 issue: 4 year: 2004 ident: 21_18528270 publication-title: Calcified Tissue International doi: 10.1007/s00223-004-0224-8 contributor: fullname: Sottile – volume: 4 start-page: 181 year: 2007 ident: 2_41528662 publication-title: DIABETES VASCULAR DISEASE RESEARCH doi: 10.3132/dvdr.2007.039 – volume: 11 start-page: 219 year: 2010 ident: 6_41528663 publication-title: REVIEWS IN ENDOCRINE METABOLIC DISORDERS doi: 10.1007/s11154-010-9153-1 – volume: 11 start-page: 11 year: 2011 ident: 23_41528668 publication-title: BMC ENDOCRINE DISORDERS doi: 10.1186/1472-6823-11-11 – volume: 9 start-page: 10 year: 2009 ident: 24_41528669 publication-title: BMC ENDOCRINE DISORDERS doi: 10.1186/1472-6823-9-10 – volume: 19 start-page: 171 issn: 1045-4403 issue: 3 year: 2009 ident: 3_35911863 publication-title: Critical reviews in eukaryotic gene expression doi: 10.1615/CritRevEukarGeneExpr.v19.i3.10 contributor: fullname: Boyce – volume: 20 start-page: 333 issn: 0957-9672 issue: 4 year: 2009 ident: 13_35042096 publication-title: Current opinion in lipidology doi: 10.1097/MOL.0b013e32832dd4b1 contributor: fullname: Karpe – volume: 30 start-page: 894 issn: 0276-5047 issue: 5 year: 2010 ident: 16_37042585 publication-title: Arteriosclerosis, Thrombosis, and Vascular Biology doi: 10.1161/ATVBAHA.108.179689 contributor: fullname: Lalloyer – volume: 355 start-page: 2427 issn: 0028-4793 issue: 23 year: 2006 ident: 12_23029165 publication-title: New England Journal of Medicine doi: 10.1056/NEJMoa066224 – volume: 50 start-page: 685 issn: 0022-2623 issue: 4 year: 2007 ident: 20_23719989 publication-title: Journal of medicinal chemistry doi: 10.1021/jm058056x contributor: fullname: Sierra – volume: 57 start-page: 385 issn: 0079-9963 issue: 1 year: 2002 ident: 17_17057524 publication-title: Recent Progress in Hormone Research doi: 10.1210/rp.57.1.385 contributor: fullname: Manolagas – volume: 92 start-page: 1305 issn: 0021-972X issue: 4 year: 2007 ident: 8_23578884 publication-title: Journal of Clinical Endocrinology & Metabolism doi: 10.1210/jc.2006-2646 – volume: 8 start-page: 71 year: 2008 ident: 9_41528664 publication-title: BMC DEVELOPMENTAL BIOLOGY doi: 10.1186/1471-213X-8-71 – volume: 3 start-page: S131 issn: 1555-9041 issue: Supplement_3 year: 2008 ident: 5_32284895 publication-title: Clinical Journal of the American Society of Nephrology doi: 10.2215/CJN.04151206 contributor: fullname: Clarke |
SSID | ssj0015173 |
Score | 2.137747 |
Snippet | Peroxisome proliferator-activated receptor (PPAR) γ agonists, such as pioglitazone (Pio), improve glycemia and lipid profile but are associated with bone loss... Peroxisome proliferator-activated receptor (PPAR) gamma agonists, such as pioglitazone (Pio), improve glycemia and lipid profile but are associated with bone... |
SourceID | proquest crossref pubmed pascalfrancis bioscientifica |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 179 |
SubjectTerms | Adiposity - drug effects Animals Biological and medical sciences Biomarkers - blood Body composition Bone (trabecular) Bone and Bones - chemistry Bone and Bones - drug effects Bone composition Bone Density - drug effects Bone Density Conservation Agents - administration & dosage Bone Density Conservation Agents - therapeutic use Bone loss Bone mass Bone mineral content Bone mineral density Bone Resorption - chemically induced Bone Resorption - etiology Bone Resorption - prevention & control Collagen Type I - blood Data processing Diseases of the osteoarticular system Drug Therapy, Combination Female Femur Fenofibrate Fenofibrate - administration & dosage Fenofibrate - therapeutic use Fractures Fundamental and applied biological sciences. Psychology Humans Hypoglycemic Agents - administration & dosage Hypoglycemic Agents - adverse effects Hypoglycemic Agents - therapeutic use Hypolipidemic Agents - administration & dosage Hypolipidemic Agents - adverse effects Hypolipidemic Agents - therapeutic use Lipids Medical sciences Menopause Metaphysis Osteocalcin - blood Osteoporosis, Postmenopausal - blood Osteoporosis, Postmenopausal - drug therapy Osteoporosis, Postmenopausal - physiopathology Osteoporosis. Osteomalacia. Paget disease Ovariectomy Peptides - blood Peroxisome proliferator-activated receptors pioglitazone PPAR alpha - agonists PPAR gamma - agonists Random Allocation Rats Regular papers Risk assessment Spine (lumbar) Thiazolidinediones - administration & dosage Thiazolidinediones - adverse effects Thiazolidinediones - therapeutic use Vertebrates: endocrinology |
Title | Combination treatment with pioglitazone and fenofibrate attenuates pioglitazone-mediated acceleration of bone loss in ovariectomized rats |
URI | http://dx.doi.org/10.1530/JOE-11-0356 https://www.ncbi.nlm.nih.gov/pubmed/22062085 https://search.proquest.com/docview/1028079679 https://search.proquest.com/docview/916150590 |
Volume | 212 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKkBATINhghI_JSBMPoEDruGn6WFDLhNZNglbqW2Q7zlRpTao1AdEnXvmvubPTfIgWDV6iNjrZln4_--6c-yDkxGNxW8FOcvtcKiyqzV0RdZWrYiFjgdnoJpF2fO6fTvnnWXfWav2sRS3lmXyn1lvzSv4HVXgHuGKW7D8gWw4KL-A34AtPQBieN8IYNjM4thbCKmLcXK0u5-kl1t9ep4n9QBDrBOaSWBniLdbUTHK0MhtyrkkjQRNUKAXq6Lo0JyWOcgX6FK9H0m_oX6ssXczXIAtSqx0mrk6iFE6l5tX9V7EQUWx5-EUkpVoYfE9t1vtYXGFeU3lRoBNgsRa5OcYukyro8YPIbcv3EawnKsKMixsMDAUpo0GqjIJ2zzbb3JzKrMNq9GO1M7Zju88U6rpjK2n_oQm6nmlyfTE0iYNed0u97fOLcDQ9Owsnw9nkFrnNYAUYFPppVgYJgTlUxCgUKywyPGHw97Wh98l9Obe1R02AV9PIubcUK9hvsW2UstuTMRbN5CF5UOBEB5ZXj0hLJwfkcAB8Shc_6GtqgoMNdAfkzriIwTgkv2qsoyXrKLKO1tlEgXW0xjpasY5uZR2ts46mMUXWUWQdncP_Busosu4xmY6Gk4-nbtHQw5Xca2eurzSPmfJ411OekEz2IqlAp3hcaXAzOIv8HhOewCqYni-wMFIgQQP5rKcCBc7KE7KXwNRPCfXB8BeBlhzkeQBuTMDbAsDSMBT3O75D3jQhCZe2ekuIXi_gFwJ-4P6GiJ9DTjZw_V3suAFlKYsFJbB0nUNebbAN4ZTGT28i0Wm-CtGMB_74vb5D6A6ZPjpfmAvukCPLi2oC1vaxme6zG0zwnNytNtkLspdd5_olGM6ZPDbc_g04p8wu |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Combination+treatment+with+pioglitazone+and+fenofibrate+attenuates+pioglitazone-mediated+acceleration+of+bone+loss+in+ovariectomized+rats&rft.jtitle=Journal+of+endocrinology&rft.au=Samadfam%2C+Rana&rft.au=Awori%2C+Malaika&rft.au=Benardeau%2C+Agnes&rft.au=Bauss%2C+Frieder&rft.date=2012-02-01&rft.issn=0022-0795&rft.volume=212&rft.issue=2&rft.spage=179&rft.epage=186&rft_id=info:doi/10.1530%2FJOE-11-0356&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-0795&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-0795&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-0795&client=summon |